Abdallah Flaifel

2.0k total citations
21 papers, 440 citations indexed

About

Abdallah Flaifel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Abdallah Flaifel has authored 21 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 6 papers in Surgery. Recurrent topics in Abdallah Flaifel's work include Renal cell carcinoma treatment (11 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Abdallah Flaifel is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Abdallah Flaifel collaborates with scholars based in United States, Lebanon and United Kingdom. Abdallah Flaifel's co-authors include Sabina Signoretti, Toni K. Choueiri, David A. Braun, Ying‐Bei Chen, Victor E. Reuter, Gordon J. Freeman, John A. Steinharter, David F. McDermott, Lauren C. Harshman and Bradley A. McGregor and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Clinical Pathology.

In The Last Decade

Abdallah Flaifel

20 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdallah Flaifel United States 11 259 179 175 119 65 21 440
Chengyan Zhang China 10 101 0.4× 144 0.8× 153 0.9× 73 0.6× 32 0.5× 24 346
Cecilia Egoavil Spain 12 53 0.2× 139 0.8× 164 0.9× 163 1.4× 35 0.5× 20 380
Rosemary Lord United Kingdom 11 55 0.2× 119 0.7× 182 1.0× 27 0.2× 44 0.7× 34 396
Arun Gopinath United States 9 90 0.3× 95 0.5× 75 0.4× 39 0.3× 25 0.4× 25 299
Inbal Kedar Israel 15 61 0.2× 120 0.7× 76 0.4× 67 0.6× 42 0.6× 42 383
Sidrah Shah United Kingdom 9 97 0.4× 128 0.7× 168 1.0× 102 0.9× 40 0.6× 11 371
Alberto Villanueva Spain 8 38 0.1× 176 1.0× 163 0.9× 56 0.5× 67 1.0× 12 419
Yehoshua Gdor United States 12 172 0.7× 132 0.7× 89 0.5× 45 0.4× 89 1.4× 18 404
Mihai Vasile Marinca Romania 8 66 0.3× 57 0.3× 136 0.8× 57 0.5× 21 0.3× 31 253

Countries citing papers authored by Abdallah Flaifel

Since Specialization
Citations

This map shows the geographic impact of Abdallah Flaifel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdallah Flaifel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdallah Flaifel more than expected).

Fields of papers citing papers by Abdallah Flaifel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdallah Flaifel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdallah Flaifel. The network helps show where Abdallah Flaifel may publish in the future.

Co-authorship network of co-authors of Abdallah Flaifel

This figure shows the co-authorship network connecting the top 25 collaborators of Abdallah Flaifel. A scholar is included among the top collaborators of Abdallah Flaifel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdallah Flaifel. Abdallah Flaifel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flaifel, Abdallah, et al.. (2024). A required medical student collaborative case presentation with a pathologist in the surgery clerkship. Academic Pathology. 11(4). 100147–100147.
2.
Flaifel, Abdallah, et al.. (2023). Significance of the Percentage of Gleason Pattern 4 at Prostate Biopsy in Predicting Adverse Pathology on Radical Prostatectomy: Application in Active Surveillance. American Journal of Clinical Pathology. 160(1). 35–40. 6 indexed citations
3.
Denize, Thomas, Subrina Farah, Alessia Cimadamore, et al.. (2021). Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial. Clinical Cancer Research. 28(4). 748–755. 12 indexed citations
4.
Flaifel, Abdallah, Jane P. Ko, Stephanie H. Chang, et al.. (2021). Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung Transplantation. American Journal of Clinical Pathology. 157(6). 908–926. 10 indexed citations
5.
Meyer, Jessica A., Ashley S. Roman, Meghana Limaye, et al.. (2021). Association of SARS-CoV-2 placental histopathology findings with maternal–fetal comorbidities and severity of COVID-19 hypoxia. The Journal of Maternal-Fetal & Neonatal Medicine. 35(25). 8412–8418. 14 indexed citations
6.
Ficial, Miriam, Opeyemi A. Jegede, Yue Hou, et al.. (2020). Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 27(5). 1371–1380. 51 indexed citations
7.
Placantonakis, Dimitris G., Maria E. Aguero‐Rosenfeld, Abdallah Flaifel, et al.. (2020). SARS-CoV-2 Is Not Detected in the Cerebrospinal Fluid of Encephalopathic COVID-19 Patients. Frontiers in Neurology. 11. 587384–587384. 20 indexed citations
8.
Flaifel, Abdallah, et al.. (2020). Characteristics of Breast Cancer Metastasizing to Bone in a Mediterranean Population. Cureus. 12(11). e11679–e11679. 1 indexed citations
9.
Flaifel, Abdallah, et al.. (2020). Investigating the spectrum of dermatologic manifestations in COVID‐19 infection in severely ill patients: A series of four cases. Journal of Cutaneous Pathology. 48(1). 110–115. 7 indexed citations
10.
Bakouny, Ziad, David A. Braun, Sachet A. Shukla, et al.. (2020). Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma (S/R RCC) to reveal potential determinants of poor prognosis and response to immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 38(6_suppl). 715–715. 3 indexed citations
11.
Tripathi, Abhishek, Edwin Lin, Wanling Xie, et al.. (2020). Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 8(2). e001467–e001467. 26 indexed citations
12.
Flaifel, Abdallah, et al.. (2020). Testicular Changes Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Archives of Pathology & Laboratory Medicine. 145(1). 8–9. 40 indexed citations
13.
Flaifel, Abdallah, Wanling Xie, David A. Braun, et al.. (2019). PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN. Clinical Cancer Research. 25(20). 6080–6088. 48 indexed citations
14.
15.
Bakouny, Ziad, Natalie I. Vokes, Xīn Gào, et al.. (2019). Efficacy of immune checkpoint inhibitors (ICI) and genomic characterization of sarcomatoid and/or rhabdoid (S/R) metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 37(15_suppl). 4514–4514. 6 indexed citations
16.
McGregor, Bradley A., Rana R. McKay, David A. Braun, et al.. (2019). Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features. Journal of Clinical Oncology. 38(1). 63–70. 108 indexed citations
17.
Alaiwi, Sarah Abou, Amin H. Nassar, Ziad Bakouny, et al.. (2019). Association of polybromo-associated BAF (PBAF) complex mutations with overall survival (OS) in cancer patients (pts) treated with checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. 37(15_suppl). 103–103. 5 indexed citations
18.
Flaifel, Abdallah, et al.. (2018). Patterns of pathologically confirmed metastasis to bone in Near East population. Cancer Epidemiology. 54. 7–11. 1 indexed citations
19.
Signoretti, Sabina, Abdallah Flaifel, Ying‐Bei Chen, & Victor E. Reuter. (2018). Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers. Journal of Clinical Oncology. 36(36). 3553–3559. 49 indexed citations
20.
Pignon, Jean‐Christophe, Opeyemi A. Jegede, Christine E. Horak, et al.. (2018). Evaluation of predictive biomarkers for nivolumab in metastatic clear cell renal cell carcinoma (mccRCC) using RECIST and immune-related (IR) RECIST.. Journal of Clinical Oncology. 36(6_suppl). 619–619. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengyan Zhang Breakdown of academic impact, for papers by Cecilia Egoavil Breakdown of academic impact, for papers by Rosemary Lord Breakdown of academic impact, for papers by Arun Gopinath Breakdown of academic impact, for papers by Inbal Kedar Breakdown of academic impact, for papers by Sidrah Shah Breakdown of academic impact, for papers by Alberto Villanueva Breakdown of academic impact, for papers by Yehoshua Gdor Breakdown of academic impact, for papers by Mihai Vasile Marinca
Rankless by CCL
2026